Effects of antihypertensive therapy on cardiac function

Area of Science:

• Cardiovascular medicine
• Pharmacology

Background:

• Clinical trials for hypertension treatment have not demonstrated protection against coronary heart disease mortality.
• Concerns exist regarding lipid disturbances with diuretics and non-intrinsic sympathomimetic activity (ISA) beta-blockers.
• Negative inotropic effects of beta-blockers are also a significant concern in hypertension management.

Purpose of the Study:

• To re-evaluate the indications and therapeutic strategies for hypertension management.
• To explore the suitability of vasodilators as a primary treatment modality.
• To identify specific calcium channel blockers with favorable safety profiles.

Main Methods:

• Review of existing clinical trial data and pharmacological profiles of antihypertensive agents.
• Comparative analysis of different drug classes, including vasodilators (alpha-blockers, ACE inhibitors, calcium channel blockers).
• Focus on the specific properties of calcium channel blockers, particularly nicardipine.

Main Results:

• Widespread use of vasodilators is suggested as an appropriate therapeutic approach.
• Nicardipine emerges as a promising calcium channel blocker.
• Nicardipine's lack of negative inotropism is a key advantageous characteristic.

Conclusions:

• Reconsideration of hypertension treatment is necessary due to trial outcome failures.
• Vasodilators, especially calcium channel blockers like nicardipine, offer a potentially safer alternative.
• Nicardipine's profile makes it an attractive option for managing hypertension, particularly concerning cardiac function.